Concepedia

Author

Yusuke Funaoka

Tokyo Medical and Dental University

Also Known As

Izumi Onozuka, Y. Funaoka, Yusuke Funaoka

10

Publications

380

Citations

8

H-Index

21

Concepts

All Affiliations

Tokyo Medical and Dental UniversitySoka Municipal Hospital
YF

About

Yusuke Funaoka is an author at Tokyo Medical and Dental University specializing in immunology, medicine, and hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

161

2

Immunology

4

4

161

3

Cell Biology

1

1

30

4

Hepatology

1

1

58

5

Microbiology

1

1

51

Yusuke Funaoka

×

7

Publications

353

Citations

7

H-Index

YearCitations

Antiviral effects of the interferon‐induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein†

Yasuhiro Itsui, Naoya Sakamoto, Sei Kakinuma,

Hepatology

2009

163

Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice

Izumi Onozuka, Sei Kakinuma, Akihide Kamiya,

Biochemical and Biophysical Research Communications

2011

58

Analysis of Interferon Signaling by Infectious Hepatitis C Virus Clones with Substitutions of Core Amino Acids 70 and 91

Yusuke Funaoka, Naoya Sakamoto, Goki Suda,

Journal of Virology

2011

51

Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells

Yuki Nishimura‐Sakurai, Naoya Sakamoto, Kaoru Mogushi,

Journal of Gastroenterology

2009

30

IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones

Goki Suda, Naoya Sakamoto, Yasuhiro Itsui,

Virology

2010

22

Inhibitory Effect of a Triterpenoid Compound, with or without Alpha Interferon, on Hepatitis C Virus Infection

Takako Watanabe, Naoya Sakamoto, Mina Nakagawa,

Antimicrobial Agents and Chemotherapy

2011

18

Establishment of a patient‑derived mucoepidermoid carcinoma cell line with the <i>CRTC1‑MAML2</i> fusion gene

Kazuma Noguchi, Shuji Kanda, Kazunari Yoshida,

Molecular and Clinical Oncology

2022

11

Page 1